temozolomide has been researched along with Leukemia, Myelomonocytic, Acute in 1 studies
Leukemia, Myelomonocytic, Acute: A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A pilot clinical study indicates that dacarbazine can induce a marked decrease of leukemic blasts in patients affected by acute myelogenous leukemia (AML) with low pretreatment levels of OGAT activity." | 5.08 | Cisplatin increases sensitivity of human leukemic blasts to triazene compounds. ( Bonmassar, E; Caravita, T; D'Atri, S; Franchi, A; Graziani, G; Papa, G; Piccioni, D, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piccioni, D | 1 |
| D'Atri, S | 1 |
| Papa, G | 1 |
| Caravita, T | 1 |
| Franchi, A | 1 |
| Bonmassar, E | 1 |
| Graziani, G | 1 |
1 trial available for temozolomide and Leukemia, Myelomonocytic, Acute
| Article | Year |
|---|---|
Cisplatin increases sensitivity of human leukemic blasts to triazene compounds.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Cisplatin; Dacarbazine; D | 1995 |